Penumbra, Inc. (PEN) is a publicly traded Healthcare sector company. As of November 18, 2026, PEN trades at $319.16 with a market cap of $12.64B and a P/E ratio of 77.67. PEN moved -0.47% today. Year to date, PEN is +1.30%; over the trailing twelve months it is +14.58%. Its 52-week range spans $221.26 to $362.41. Analyst consensus is neutral with an average price target of $366.00. Rallies surfaces PEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover PEN: 0 strong buy, 0 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $366.00.
| Metric | Value |
|---|---|
| Price | $319.16 |
| Market Cap | $12.64B |
| P/E Ratio | 77.67 |
| EPS | $4.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $362.41 |
| 52-Week Low | $221.26 |
| Volume | 325.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.50B |
| Net Income | $160.59M |
| Gross Margin | 67.84% |
3 analysts cover PEN: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $366.00.